NR 6/2003
|
|
|
|
|
|
|
|
|
Skuteczność kliniczna ciprofloksacyny 0,3%
(Ciloxan) w leczeniu infekcji bakteryjnych aparatu ochronnego oka
Clinical efficacy of ciprofloxacin 0,3% (Ciloxan) in
the treatment of bacterial infections of external eye segment
Andrzej Stankiewicz, Mariusz Kosatka, Arkadiusz Goś
Z Kliniki Okulistycznej Wojskowego Instytutu Medycznego
Centralny Szpital Kliniczny Ministerstwa Obrony Narodowej w Warszawie
Kierownik: prof. dr hab. n. med. Andrzej Stankiewicz |
|
|
| Summary: |
Purpose: The main subject of the study was
to evaluate efficacy of ciprofloxacin 0,3% ophthalmic solution (Ciloxan) in the treatment
of bacterial conjunctivitis and surgical prophylaxis. Safety and comfort of topical
ciprofloxacin treatment was also examined.
Material and methods: Two study arms: 99 patients with bacterial
conjunctivitis (A group) and 48 patients awaiting cataract surgery (B group - total 147
subjects in both groups) received ciprofloxacin 0,3% ophthalmic solution (Ciloxan) 4 doses
a day for seven days. Bacteriological evaluation was established before and after
treatment for each eye.
Results: 95 out of the 99 patients (96%) in the first arm were completely
cured (all signs and symptoms of the bacterial conjunctivitis were eliminated). In the
second arm complete eradication of bacterial flora was achieved in 46 out of 48 pretreated
patients (96%)
Conclusions: Topical ciprofloxacin 0,3% (iloxan) was found very effective
and fast in reduction of typical signs and symptoms of bacterial conjunctivitis as well as
in eradication of bacterial flora before surgery treatment. |
| Słowa kluczowe: |
ciprofloksacyna, bakteryjne zapalenie spojówek,
profilaktyka okołooperacyjna. |
| Key words: |
ciprofloxacin, bacterial conjunctivitis and ocular surgery. |
|
|
|
|
|
|
